11 min read
The GLP-1 Off-Ramp: Opportunity for Supplement Founders
When consumers stop GLP-1 drugs like Ozempic, rapid weight regain creates a supplement opening. Here's how brand founders can position for the GLP-1 off-ramp.
GLP-1 Support supplement manufacturing
The biggest new formulation brief coming across our desk right now.
As millions of consumers cycle on and off GLP-1 medications like semaglutide and tirzepatide, a category is forming around muscle preservation, satiety support, gut health, and metabolic bridging. It's the brief we see more of than any other in 2026.
GLP-1 is reshaping the supplement industry faster than anything else we've seen this decade. Millions of consumers are cycling through semaglutide and tirzepatide prescriptions, and a lot of them are coming off. That's creating four very specific supplement needs: muscle preservation during rapid weight loss, satiety support after people come off the medication, gut health to deal with GI side effects, and metabolic bridging through the off-ramp.
GLP-1 support blends tend to pull from the same ingredient toolkit: protein sources (creatine, leucine, collagen), soluble fibers (glucomannan, PHGG), electrolytes, B-vitamins, and in some cases targeted botanicals like berberine, bitter melon, or inositol. The hardest part of this category isn't formulation. It's claim language. Any wording that implies the product treats, replaces, or substitutes for a prescription drug is a warning letter waiting to happen. We help brands build claim structures that stay on the right side of the line in both Canada and the USA.
Why brands choose GLP-1 Support Blend
Nobody owns it yet
No dominant brand has captured the GLP-1 support category so far. The brands moving first have a real chance to plant a flag before it gets crowded.
Multiple product angles from one positioning
On-GLP-1, off-GLP-1, and maintenance consumers each need different things. One brand position can support three or four distinct SKUs.
Consumers who already pay premium prices
This cohort has proven they'll pay for weight-management results. They're not price-sensitive shoppers.
Formulation notes
Working with GLP-1 Support Blend
- Typical stacks include protein + fiber + electrolytes + targeted actives.
- Avoid any claim language that implies drug replacement or treatment of GLP-1 side effects. This is the #1 compliance risk.
- Stick packs and powders are the favored formats because of dose volume and mixability.
- Consider berberine, bitter melon, or inositol as targeted metabolic actives (with regulatory review).
Delivery Forms
PowderStick packCapsuleReady-to-drink
Considerations
- Compliance is the single biggest risk in this category. Claim language must be carefully engineered.
- Ingredient interactions with GLP-1 medications are an emerging research area; conservative positioning is recommended.
What a first run of GLP-1 Support costs
The published minimums and typical costs for GLP-1 Support. Every project gets an itemized quote covering your format, ingredients, and packaging.
| Dosage form | Minimum order |
|---|---|
| GLP-1 Support powders | from 1,000 units |
| GLP-1 Support capsules | from 2,000 units |
Lead time
6 to 10 weeks from the catalog (network range 4 to 12 weeks). A custom formula takes 8 to 12 weeks before production.
First run
2,000 units usually lands at USD $8,000 to $15,000 all-in, depending on format, ingredient grade, and packaging.
Always included
GMP-certified manufacturing, a third-party ISO 17025 Certificate of Analysis on every batch, regulatory handling, and one account lead.
Formula feasibility reviews are free. Get an itemized quote for your format and volume.
Regulatory status
Canada (NPN)
All constituent ingredients must have NPN monograph coverage or full submissions. Claim structure must stay within NHP regulations.
USA (DSHEA)
DSHEA structure-function claims only. Avoid any disease claim or implied treatment of GLP-1 side effects.
Common Structure-Function Claims
- Supports healthy protein intake during weight management
- Supports digestive comfort
- Helps support satiety as part of a balanced lifestyle
Claim language must be reviewed for your specific product and market before use. Not all claims are permitted in every jurisdiction.
Clinical evidence and market demand
Selected peer-reviewed studies, plus the demand signals we're seeing from brands, retailers, and consumer search behaviour.
Primary literature
Cava E, Yeat NC, Mittendorfer B. · Advances in Nutrition · 2017
Foundational reference for protein and resistance-training requirements during rapid weight loss. The muscle-preservation pillar of every GLP-1 stack.
- Efficacy of berberine in patients with type 2 diabetes mellitus: a systematic review and meta-analysisMeta-analysis
Lan J, Zhao Y, Dong F, et al. · Journal of Ethnopharmacology · 2015
Pooled data showing berberine produces clinically meaningful improvements in fasting glucose, HbA1c, and lipids. Underpins the metabolic-bridging positioning.
- Glucomannan supplementation in overweight and obese adults: a systematic review and meta-analysisMeta-analysis
Onakpoya I, Posadzki P, Ernst E. · Journal of the American College of Nutrition · 2014
Modest effect on body weight, stronger effect on LDL. Supporting evidence for soluble-fiber satiety components in GLP-1 stacks.
Jensen SBK, Blond MB, Sandsdal RM, et al. · The Lancet Diabetes & Endocrinology · 2023
Quantifies the share of GLP-1-induced weight loss that comes from lean mass (~25 to 40%). The clinical motivation for muscle-preservation supplements.
Market & consumer demand
GLP-1 companion supplements are the largest greenfield supplement category in 2025, with no dominant brand yet established.
By mid-2025, roughly 12% of US adults reported having taken or considered a GLP-1 medication. That cohort is generating four distinct supplement product briefs: muscle preservation during use, satiety support after discontinuation, GI comfort during titration, and metabolic maintenance during the off-ramp. Every major supplement retailer has carved out shelf space for "GLP-1 companion" SKUs, but the early entries have been protein powders with GLP-1 marketing rather than purpose-built formulas. Brands entering now have a 12 to 18 month window before category leaders emerge.
- NielsenIQ: Weight management category report 2024: Identifies GLP-1 companion as the highest-growth subcategory in supplements, with $400M+ in projected 2025 revenue.
- Examine.com: Berberine: Strong evidence base for glycemic and lipid effects. The most-studied of the GLP-1 stack metabolic actives.
References are provided for educational purposes. Citations do not constitute medical claims or guarantee outcomes. Structure-function claim language must be reviewed for your specific product and market.
Common questions about GLP-1 Support manufacturing
For GLP-1 Support the floors are powders from 1,000 units, capsules from 2,000 units. These are entry minimums. The same formula scales past 100,000 units as it sells.
A white-label or private-label GLP-1 Support product from our 800+ formula catalog typically runs 6 to 10 weeks, and 4 to 12 weeks across the full network depending on which facility takes the run. A custom GLP-1 Support formula takes 8 to 12 weeks to reach a production-ready formulation, then production on top.
A first run of 2,000 units is usually USD $8,000 to $15,000 all-in, depending on format, ingredient grade, and packaging. That covers formulation work, regulatory, packaging, quality testing, and the production run itself. Coordinated through us a project typically lands 20 to 40% below managing the same production in-house. You get an itemized quote before committing.
Canada: All constituent ingredients must have NPN monograph coverage or full submissions. Claim structure must stay within NHP regulations. United States: DSHEA structure-function claims only. Avoid any disease claim or implied treatment of GLP-1 side effects. We prepare and file the NPN application for Canada and handle FDA facility registration and DSHEA label review for the US, including bilingual labels for dual-market SKUs.
Nothing that implies drug replacement or treating the side effects of GLP-1 medications. That is the single biggest compliance risk in the category and the fastest route to a rejected NPN or an FDA warning letter. Claim language here has to be engineered deliberately, and we review it before anything is printed.
Stick packs and powders. The dose volume in a typical support blend is too large for capsules, and powders mix into the shakes and drinks this audience is already using. Powders carry the lower 1,000-unit floor as well.
Most stacks are built on protein, fiber, and electrolytes, with targeted actives on top. That base addresses the practical complaints of the audience and is straightforward to substantiate.
Berberine, bitter melon, or inositol are the common choices, each subject to regulatory review for your market. Ingredient interactions with GLP-1 medications are an emerging research area, so we take a conservative position on both formula and claims.
Related services
Related ingredients
Ready to build with GLP-1 Support Blend?
Tell us about your product concept and we'll put together a formulation, sourcing, and manufacturing plan tailored to your brand, format, and market.